ONALABS has been selected by the acceleration platform CIMTI to focus and strengthen the strategic line of non-invasive devices. CIMTI has evaluated the idea and technological impact of the value proposal of ONALABS, and the viability of the innovative solution of monitoring chronic cardiorespiratory remotely.